Nodular thyroid disease fine needle aspiration: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Nodular thyroid disease}} {{CMG}} == Overview == == Fine Needle Aspiration == * Fine needle aspiration (FNA) should otherwise be the first step in the eval...") |
No edit summary |
||
| Line 6: | Line 6: | ||
== Fine Needle Aspiration == | == Fine Needle Aspiration == | ||
* [[Fine needle aspiration]] (FNA) should otherwise be the first step in the evaluation of a thyroid nodule | * [[Fine needle aspiration]] (FNA) should otherwise be the first step in the evaluation of a thyroid nodule. The results are usually reported as [[benign]], [[malignant]] or indeterminate (suspicious). | ||
* Most results (~ 70 - 80%) do not reveal malignancy (however ~ 11% are indeterminate, and ~11% are inadequate). | * Most results (~ 70 - 80%) do not reveal malignancy (however ~ 11% are indeterminate, and ~11% are inadequate). | ||
*:* These patients can be followed clinically with [[ultrasound]] and repeat FNA in 6 months to 1 year. The rate of false negatives is ~ 1-6% and results from sampling errors or inadequate specimens (repeat biopsy is adequate in 50% of these cases). | *:* These patients can be followed clinically with [[ultrasound]] and repeat FNA in 6 months to 1 year. The rate of false negatives is ~ 1-6% and results from sampling errors or inadequate specimens (repeat biopsy is adequate in 50% of these cases). | ||
Latest revision as of 14:29, 19 September 2012
|
Nodular thyroid disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nodular thyroid disease fine needle aspiration On the Web |
|
American Roentgen Ray Society Images of Nodular thyroid disease fine needle aspiration |
|
Risk calculators and risk factors for Nodular thyroid disease fine needle aspiration |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fine Needle Aspiration
- Fine needle aspiration (FNA) should otherwise be the first step in the evaluation of a thyroid nodule. The results are usually reported as benign, malignant or indeterminate (suspicious).
- Most results (~ 70 - 80%) do not reveal malignancy (however ~ 11% are indeterminate, and ~11% are inadequate).
- These patients can be followed clinically with ultrasound and repeat FNA in 6 months to 1 year. The rate of false negatives is ~ 1-6% and results from sampling errors or inadequate specimens (repeat biopsy is adequate in 50% of these cases).
- Hashimoto’s thyroiditis is the most common cause of the 4-6% false positive rate.
- ~ 20% of indeterminate biopsies turn out to be malignant (usually follicular cancer).
References